Literature DB >> 30368740

Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study.

Derya Ozturk-Engin1, Hakan Erdem2, Rodrigo Hasbun3, Shu-Hua Wang4, Hulya Tireli5, Pierre Tattevin6, Xavier Argemi7, Enora Ouamara-Digue6, Andrea Gombos8, Botond Lakatos8, Fatma Sırmatel9, Yasemin Cag10, Abdullah Umut Pekok11, Seniha Senbayrak12, Ilker Inanç Balkan13, Marie Gheno6, Nuray Uzun14, Selçuk Kaya15, Gönül Cicek-Senturk16, Gönül Şengöz17, Recep Tekin18, Mustafa Kemal Çelen18, Saygın Nayman-Alpat19, Pınar Ergen10, Alper Şener20, Canan Agalar21, Sükran Köse22, Ahmet Çagkan Inkaya23, Figen Kaptan24, Fahad Al-Majid25, Umit Savasci26, Haluk Vahaboglu10.   

Abstract

Neurosyphilis (NS) has different clinical manifestations and can appear during any stage of syphilis. We aimed to identify the factors affecting poor outcome in NS patients. Patients with positive cerebrospinal fluid Venereal Disease Research Laboratory test, and positive serological serum treponemal or nontreponemal tests were classified as definite NS. The data of 141 patients with definite NS were submitted from 22 referral centers. Asymptomatic NS, syphilitic meningitis, meningovascular syphilis, tabes dorsalis, general paresis, and taboparesis were detected in 22 (15.6%), 67 (47.5%), 13 (9.2%), 10 (7%), 13 (9.2%), and 16 patients (11.3%), respectively. The number of HIV-positive patients was 43 (30.4%). The most common symptoms were headache (n = 55, 39%), fatigue (n = 52, 36.8%), and altered consciousness (50, 35.4%). Tabetic symptoms were detected in 28 (19.8%), paretic symptoms in 32 (22.6%), and vascular symptoms in 39 patients (27.6%). Eye involvement was detected in 19 of 80 patients (23.7%) who underwent eye examination and ear involvement was detected in eight of 25 patients (32%) who underwent ear examination. Crystallized penicillin was used in 109 (77.3%), procaine penicillin in seven (4.9%), ceftriaxone in 31 (21.9%), and doxycycline in five patients (3.5%). According to multivariate regression analysis, while headache was a protective factor in NS patients, double vision was significantly associated to poor outcome. We concluded that double vision indicated unfavorable outcome among NS patients. A high clinical suspicion is needed for the diagnosis NS. As determined in our study, the presence of headache in syphilitic patients can help in early diagnosis of central nervous system disease.

Entities:  

Keywords:  Cerebrospinal fluid; Neurosyphilis; Outcome; Syphilis; VDRL

Mesh:

Substances:

Year:  2018        PMID: 30368740     DOI: 10.1007/s10096-018-3403-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Treatment of neurosyphilis with ceftriaxone.

Authors:  S Shann; J Wilson
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

2.  Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus.

Authors:  S Lena Kang-Birken; Uldine Castel; John G Prichard
Journal:  Pharmacotherapy       Date:  2010-04       Impact factor: 4.705

Review 3.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Incidence and clinical presentation of neurosyphilis: a retrospective study of 81 cases.

Authors:  C H Mitsonis; E Kararizou; N Dimopoulos; N Triantafyllou; E Kapaki; P Mitropoulos; K Sfagos; D Vassilopoulos
Journal:  Int J Neurosci       Date:  2008-09       Impact factor: 2.292

Review 5.  REVIEW: Neurosyphilis: A historical perspective and review.

Authors:  Khalil G Ghanem
Journal:  CNS Neurosci Ther       Date:  2010-07-08       Impact factor: 5.243

Review 6.  Late-stage neurosyphilis presenting with severe neuropsychiatric deficits: diagnosis, therapy, and course of three patients.

Authors:  Sabine Ulrike Jantzen; Stefano Ferrea; Tania Langebner; Wolfgang Gaebel; Mechthild Griese; Gabriele Arendt; Marcel Dihné
Journal:  J Neurol       Date:  2011-10-01       Impact factor: 4.849

7.  Clinical spectrum of neurosyphilis among HIV-negative patients in the modern era.

Authors:  Hui-Lin Zhang; Li-Rong Lin; Gui-Li Liu; Yan-Li Zeng; Jing-Yi Wu; Wei-Hong Zheng; Man-Li Tong; Jie Dong; Yuan-Hui Su; Li-Li Liu; Tian-Ci Yang
Journal:  Dermatology       Date:  2013-04-19       Impact factor: 5.366

8.  Current clinical spectrum of neurosyphilis in immunocompetent patients.

Authors:  Miguel Angel Conde-Sendín; Raul Amela-Peris; Yolanda Aladro-Benito; Alfonso Angel-Moreno Maroto
Journal:  Eur Neurol       Date:  2004-06-28       Impact factor: 1.710

Review 9.  Clinical and imaging findings in patients with neurosyphilis: a study of a cohort and review of the literature.

Authors:  Ziad Khamaysi; Reuven Bergman; Gregory Telman; Dorith Goldsher
Journal:  Int J Dermatol       Date:  2013-11-21       Impact factor: 2.736

10.  Prognostic indicators in bacterial meningitis: a case-control study.

Authors:  Maria de Fátima Magalhães Acioly Mendizabal; Phelipe Cunha Bezerra; Diego Lins Guedes; Diogo Buarque Cordeiro Cabral; Demócrito de Barros Miranda-Filho
Journal:  Braz J Infect Dis       Date:  2013-07-05       Impact factor: 3.257

View more
  3 in total

1.  An Educational Intervention to Improve Provider Screening for Syphilis Among Men Who Have Sex with Men Utilizing an Urban Urgent Care Center.

Authors:  Dina Romo; Gowri Nagendra; Sarah Schechter; April Pavlish; Alwyn Cohall; Natalie Neu
Journal:  J Community Health       Date:  2019-08

2.  German guidelines on the diagnosis and treatment of neurosyphilis.

Authors:  Matthias Klein; Klemens Angstwurm; Stefan Esser; Kathrin Hahn; Matthias Maschke; Simone Scheithauer; Helmut Schoefer; Matthias Sturzenegger; Brigitte Wildemann; Jörg Weber
Journal:  Neurol Res Pract       Date:  2020-11-17

Review 3.  An Updated Review of Recent Advances in Neurosyphilis.

Authors:  Jia Zhou; Hanlin Zhang; Keyun Tang; Runzhu Liu; Jun Li
Journal:  Front Med (Lausanne)       Date:  2022-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.